| Business Name: |
Rana D Eila MD |
| Contact Person: |
D Eila Rana |
| Address: |
222 Route 59 # 306, Suffern, New York 10901 |
| Phone Number: |
(845) 362-1630 |
| Website Address: |
partnersinpediatricsllc.com |
| Annual Revenue (USD): |
$1.000.000 to $2.499.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Berkowitz Bennett J MD - Suffern, NY 10901
Singaravelu Dakshinamur MD - Suffern, NY 10901
Medina Felix A MD - Suffern, NY 10901
Clarkin Richard P MD - Suffern, NY 10901
Xiong Tiexin MD - Suffern, NY 10901
Palop Ricardo MD - Suffern, NY 10901
Burns Paul MD - Suffern, NY 10901
Muhlbauer David J MD - Suffern, NY 10901
Mudric-Tiganu Brindusa MD - Suffern, NY 10901
Tash Robert R MD - Suffern, NY 10901
Rosner Victor MD - Suffern, NY 10901
Song Michael M MD - Suffern, NY 10901
Bhana Mahomed MD - Suffern, NY 10901
Thomas L Facelle - Suffern, NY 10901
Peter T Simonson Pllc - Suffern, NY 10901
Tenembaum Gabriel MD - Suffern, NY 10901
Mark M S Khilnani M D P C - Suffern, NY 10901
C Melcer Md - Suffern, NY 10901
Van Roekens Craig N MD - Suffern, NY 10901
Leonard Steinfeld Inc - Suffern, NY 10901
|
The company Rana D Eila MD provides B2C services in the form of Doctors from its single location in New York.
1 to 4 employees work for Rana D Eila MD, and the business now earns $1.000.000 to $2.499.999 per annum.
Rana D Eila MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Rana D Eila MD, please call D Eila Rana with the phone number (845) 362-1630 or visit its single location at 222 Route 59 # 306 in Suffern, New York 10901.
The location of the single location can also be found using the coordinates 41.112538,-74.137156.
Read more details about this business on the webpage partnersinpediatricsllc.com or follow the company’s social media accounts, on Twitter and on Facebook.